35. Pillet,S.etal.Aplant-derivedquadrivalentviruslikeparticleinfluenzavaccine
fightagainstCOVID-19? Vaccines 8,183(2020).
34. Rosales-Mendoza,S.etal.Whatdoesplant-basedvaccinetechnologyoffertoth
expressedin Escherichiacoli. Gene 21,273–284(1983).
33. Davis, A. R. et al. Immune response to human influenza virus hemagglutinin
bacteria. ActaBiochimPol. 61,561–572(2014).
32. Saczynska, V.Influenzavirus hemagglutinin asavaccine antigen produced i
producedin Escherichiacoli. PLoSONE 5,e11694(2010).
31. Aguilar-Yanez, J. M. et al. An influenza A/H1N1/2009 hemagglutinin vaccine
proteins. OpenForumInfect.Dis. 3,ofw015(2016).
seasonal flu vaccine comprising recombinant hemagglutinin-flagellin fusion
30. Tussey, L. et al. Phase 1 safety and immunogenicity study of a quadrivalent
ONE 3,e2257(2008).
bacterial expression: a solution to global pandemic and seasonal needs. PLoS
29. Song,L.etal.Efficaciousrecombinantinfluenzavaccinesproducedbyhighyield
1560-7917.Es.2017.22.13.30494(2017).
sibles = European communicable disease bulletin 22, https://doi.org/10.2807/
visiontoreality.Eurosurveillance:bulletinEuropeensurlesmaladiestransmis-
28. Shu,Y.&McCauley,J.GISAID:Globalinitiativeonsharingallinfluenzadata-from
167–171(2017).
effectiveness-UnitedStates,February2017. MMWRMorb.Mortal.WklyRep. 66
27. Flannery, B. et al. Interim estimates of 2016-17 seasonal influenza vaccine
NatlAcad.Sci.USA 114,12578–12583(2017).
thataltersbindingofantibodieselicitedbyegg-adaptedvaccinestrains. Proc.
26. Zost,S.J.etal.ContemporaryH3N2influenzaviruseshaveaglycosylationsit
circulatingviruses. PLoSONE 9,e92153(2014).
with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift i
25. Skowronski,D.M.etal.Low2012-13influenzavaccineeffectivenessassociated
egg-adaptedvaccinestrain. Nat.Med. 22,1465–1469(2016).
24. Raymond,D.D.etal.Influenzaimmunizationelicitsantibodiesspecificforan
cells. J.Invertebr.Pathol. 107,S31–S41(2011).
23. Cox,M.M.&Hashimoto,Y.Afasttrackinfluenzavirusvaccineproducedininsect
10,702–714(2015).
manufacturingplatformforviralvaccinesandgenetherapyvectors. Biotechnol.J
22. Felberbaum, R. S. The baculovirus expression vector system: a commercia
Med. 121,S22–S27(2008).
duction,distribution,supply,anddemand–whatitmeansfortheprovider. Am.J
21. Orenstein,W.A.&Schaffner,W.Lessonslearned:roleofinfluenzavaccinepro-
placebo-controlledphaseItrial. Nat.Med. 27,106–114(2021).
vaccine approach induces broad and long-lasting immunity in a randomized,
20. Nachbagauer,R.etal.Achimerichemagglutinin-baseduniversalinfluenzavirus
vaccine:differentapproachesforonegoal. Virol.J. 15,17(2018).
19. Sautto, G. A., Kirchenbaum, G. A. & Ross, T. M. Towards a universal influenza
(2018).